Month: March 2025

Cosmo Pharmaceuticals Delivers Record 2024 Results – Completes Phase III Enrollment for Androgenetic Alopecia in Males – Proposes Increased Dividend of 2.05 per share – Reinforcing Shareholder Value and Growth Momentum into 2025

Nationally-Recognized Health Care Providers, Leading Academics and State Leaders Address Access to Cancer Treatment in Florida’s Rural Communities

Tampa General Hospital Cancer Institute hosted a day of keynotes, presentations and discussions at TGH Brooksville to address the challenges...

New Study Demonstrates Potential for Enhanced Accuracy of Blood Cultures with Steripath® Initial Specimen Diversion Device® (ISDD®) for Central Line Draws

SEATTLE, March 5, 2025 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device® (ISDD®) technology, today...

HEOR Services Market Size Booms with CAGR 12.3%, Projected to Reach $3.79 Billion by 2031 | Exclusive Report by The Insight Partners

NEW YORK, March 5, 2025 /PRNewswire/ -- According to a comprehensive report from The Insight Partners, "Health Economics and Outcome...

error: Content is protected !!